PuSH - HMGU Publikationen https://push-zb.helmholtz-munich.de PuSH - Publikationen-Server des Helmholtz Zentrums München de-de <![CDATA[van der Garde, M.* et al. Single-cell MultiOmic analysis of CHIP bone marrow stem and progenitor cells provides evidence of early-stage malignant transformation. Oncol. Res. Treat. 45, 264-265 (2022)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66716&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66716&la=de Fri, 13 Jan 2023 00:00:00 +0000 <![CDATA[Zeller, T.* et al. Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages. Oncol. Res. Treat. 45, 2, 162-162 (2022)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66717&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66717&la=de Mon, 21 Nov 2022 00:00:00 +0000 <![CDATA[Haffner, I.* et al. Treatment of HER2 positive advanced gastric cancer: Deviations in HER2 results and its impact on survival. Oncol. Res. Treat. 43, 65-65 (2020)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=58668&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=58668&la=de Wed, 25 Mar 2020 00:00:00 +0000 <![CDATA[Cheney, C.P. et al. The association between serum 25-Hydroxyvitamin D and cancer risk: Results from the prospective KORA F4 study. Oncol. Res. Treat. 41, 117-121 (2018)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=53234&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=53234&la=de Wed, 14 Mar 2018 00:00:00 +0000 <![CDATA[Haffner, I.* et al. Determination of HER2 in Gastric Cancer (GC) is still challenging: high deviation rates between local and central pathologies and its impact on survival. Oncol. Res. Treat. 41, 240-240 (2018)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=54586&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=54586&la=de Fri, 26 Oct 2018 00:00:00 +0000 <![CDATA[Pfirrmann, M.* et al. The EUTOS long-term survival (ELTS) score is superior to the Sokal score for prognosis of probabilities of dying of chronicphase chronic myeloid leukaemia. Oncol. Res. Treat. 41, 140-141 (2018)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=54585&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=54585&la=de Fri, 26 Oct 2018 00:00:00 +0000 <![CDATA[Eichner, R.* et al. Immunomodulatory drugs destabilize CD98hc and LAT1 to interfere with amino acid transport and tumor metabolism. Oncol. Res. Treat. 40, 82-82 (2017)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=52081&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=52081&la=de Tue, 17 Oct 2017 00:00:00 +0000 <![CDATA[Gary, R.* et al. Adoptive transfer of CMV- and EBV-specific peptide-stimulated T cells after allogeneic stem cell transplantation: First results of a phase I/IIa clinical trial [AIT-MULTIVIR-01]. Oncol. Res. Treat. 40, 239-239 (2017)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=52080&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=52080&la=de Tue, 17 Oct 2017 00:00:00 +0000 <![CDATA[Habringer, S.* et al. CXCR4-directed peptide receptor radiotherapy with 177Lu-Pentixather effectively clears leukemia in patient-derived xenografts. Oncol. Res. Treat. 40, 214-214 (2017)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=51591&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=51591&la=de Fri, 28 Jul 2017 00:00:00 +0000 <![CDATA[Jacobs, L.A.* et al. A study of Myc-regulated metabolic changes in transformed B cells. Oncol. Res. Treat. 40, 218-218 (2017)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=51590&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=51590&la=de Fri, 28 Jul 2017 00:00:00 +0000 <![CDATA[Krupka, C. et al. Influence of cytoreductive and immunmodulatory drugs on antibody-based approaches in AML. Oncol. Res. Treat. 40, 84-85 (2017)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=51593&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=51593&la=de Fri, 28 Jul 2017 00:00:00 +0000 <![CDATA[Lichtenegger, F.S. et al. Induction of antigen-specific T-cell responses through dendritic cell vaccination in AML: Results of a phase I/II trial and ex vivo enhancement by checkpoint blockade. Oncol. Res. Treat. 40, 135-135 (2017)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=51592&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=51592&la=de Fri, 28 Jul 2017 00:00:00 +0000 <![CDATA[Richter, A.S.* et al. CK2 inhibition reduces cell proliferation in acute B-lymphoblastic leukemia cells in vitro and in vivo. Oncol. Res. Treat. 40, 20-20 (2017)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=52082&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=52082&la=de Tue, 17 Oct 2017 00:00:00 +0000 <![CDATA[Friemel, I.* et al. Intratumor heterogeneity in hepatocellular carcinoma: Impact on tumor classifications and targeted therapies. Oncol. Res. Treat. 39, 81 (2016)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48216&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48216&la=de Sat, 02 Apr 2016 00:00:00 +0000 <![CDATA[Gross, E.* et al. Validation of a BRCAness test to select for targeted therapies in triple-negative breast cancer. Oncol. Res. Treat. 39, 54 (2016)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48218&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48218&la=de Sat, 02 Apr 2016 00:00:00 +0000 <![CDATA[Habringer, S.* et al. CXCR4-directed peptide receptor radiotherapy with 177Lu-Pentixather effectively clears leukemia in patient-derived xenografts. Oncol. Res. Treat. 39, 214-214 (2016)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=49978&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=49978&la=de Thu, 24 Nov 2016 00:00:00 +0000 <![CDATA[Haffner, I.* et al. Clinical validation of response and resistance factor candidates to targeted therapy in Gastric Cancer (GC). Oncol. Res. Treat. 39, 16-17 (2016)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48220&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48220&la=de Sat, 02 Apr 2016 00:00:00 +0000 <![CDATA[Jacobs, L.A.* et al. A study of Myc-regulated metabolic changes in transformed B cells. Oncol. Res. Treat. 39, 218-218 (2016)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=49979&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=49979&la=de Thu, 24 Nov 2016 00:00:00 +0000 <![CDATA[Krupka, C. et al. Influence of cytoreductive and immunmodulatory drugs on antibody-based approaches in AML. Oncol. Res. Treat. 39, 84-85 (2016)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=49981&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=49981&la=de Thu, 24 Nov 2016 00:00:00 +0000 <![CDATA[Lichtenedger, F.S. et al. Induction of antigen-specific T-cell responses through dendritic cell vaccination in AML: results of a phase I/II trial and ex vivo enhancement by checkpoint blockade. Oncol. Res. Treat. 39, 135-135 (2016)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=49984&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=49984&la=de Thu, 24 Nov 2016 00:00:00 +0000 <![CDATA[Neff, F.* et al. Targeting notch for myeloid reprogramming in pancreatic cancer. Oncol. Res. Treat. 39, 16 (2016)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48215&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48215&la=de Sat, 02 Apr 2016 00:00:00 +0000 <![CDATA[Trajkovic-Arsic, M.* et al. Identification of metabolic changes in pancreatic ductal adenocarcinoma. Oncol. Res. Treat. 39, 76-77 (2016)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48217&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48217&la=de Sat, 02 Apr 2016 00:00:00 +0000 <![CDATA[Willier, S.* et al. Role of Thyroid Receptor Interacting Protein 6 (TRIP6) in migration and invasion of Ewing' sarcoma cells. Oncol. Res. Treat. 39, 145 (2016)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48221&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48221&la=de Sat, 02 Apr 2016 00:00:00 +0000 <![CDATA[Bücklein, V.L. et al. Intratumoral immune cell infiltration in patients with high-grade soft-tissue sarcoma is associated with tumor grading. Oncol. Res. Treat. 38, 246-247 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47486&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47486&la=de Tue, 08 Dec 2015 00:00:00 +0000 <![CDATA[Bücklein, V.L. et al. Immunotherapeutic strategies for soft-tissue sarcoma: Preclinical results of Natural Killer cell augmentation by ex vivo expansion and use of an anti-GD2 antibody. Oncol. Res. Treat. 38, 149-150 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47488&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47488&la=de Tue, 08 Dec 2015 00:00:00 +0000 <![CDATA[Freysoldt, B. et al. Cotargeting of PIM, PI3K and mTOR in mantle cell lymphoma. Oncol. Res. Treat. 38, 63 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47490&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47490&la=de Tue, 08 Dec 2015 00:00:00 +0000 <![CDATA[Garz, A.-K.* et al. The combination of crenolanib and azacitidine effectively targets leukemia-initiating cells in FLT3-ITD+ AML to overcome protection by the bone marrow niche. Oncol. Res. Treat. 38, 214 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47489&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47489&la=de Tue, 08 Dec 2015 00:00:00 +0000 <![CDATA[Habringer, S.* et al. Very early functional in-vivo imaging to predict response to B cell receptor pathway targeting in lymphoma. Oncol. Res. Treat. 38, 99 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47482&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47482&la=de Tue, 08 Dec 2015 00:00:00 +0000 <![CDATA[Hatzl, S.* et al. Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a. Oncol. Res. Treat. 38, 99 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47483&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47483&la=de Tue, 08 Dec 2015 00:00:00 +0000 <![CDATA[Köhnke, T. ; Rechkemmer, S.* ; Bücklein, V.L. ; Hiddemann, W.* & Subklewe, M. Feasibility of semi-automated MRD analysis by flow cytometry in acute myeloid leukemia. Oncol. Res. Treat. 38, 46 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47485&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47485&la=de Tue, 08 Dec 2015 00:00:00 +0000 <![CDATA[Krupka, C. et al. Combining immune checkpoint inhibition with the CD33 BiTE (R) antibody construct AMG 330 to enhance T cell mediated lysis of primary AML cells. Oncol. Res. Treat. 38, 38 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47481&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47481&la=de Tue, 08 Dec 2015 00:00:00 +0000 <![CDATA[Lichtenegger, F.S. et al. Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I trial. Oncol. Res. Treat. 38, 37 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47480&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47480&la=de Tue, 08 Dec 2015 00:00:00 +0000 <![CDATA[Zoellner, A.-K.* et al. The B-cell receptor pathway is highly actived in canine DLBCL cell line CLBL-1. Oncol. Res. Treat. 38, 65 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47487&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47487&la=de Tue, 08 Dec 2015 00:00:00 +0000 <![CDATA[Bruns, H.* et al. Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high grade B-cell lymphoma. Oncol. Res. Treat. 37, 70 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42859&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42859&la=de Mon, 01 Dec 2014 00:00:00 +0000 <![CDATA[Harnicek, D. et al. Hyperthermia combined with trabectedin prolongs G2 cell cycle arrest and reduces cellular survival in human tumor cells. Oncol. Res. Treat. 37, 116 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=31063&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=31063&la=de Mon, 14 Apr 2014 00:00:00 +0000 <![CDATA[Hellmuth, J. et al. Gastrointestinal Follicular Lymphoma (FL) differs from nodal FL by absence of EZH2 mutations. Oncol. Res. Treat. 37, 75 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42861&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42861&la=de Mon, 01 Dec 2014 00:00:00 +0000 <![CDATA[Jansen, L.* et al. Socio-economic deprivation and cancer survival in Germany. Oncol. Res. Treat. 37, 34 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=31062&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=31062&la=de Mon, 14 Apr 2014 00:00:00 +0000 <![CDATA[Kobold, S.* et al. Bispecific T cell recruiting antibody enhances anti-tumor activity of adoptive T cell transfer. Oncol. Res. Treat. 37, 239 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42865&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42865&la=de Mon, 01 Dec 2014 00:00:00 +0000 <![CDATA[Lichtenegger, F.S. et al. T cell differentiation but not exhaustion in AML. Oncol. Res. Treat. 37, 225 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42862&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42862&la=de Mon, 01 Dec 2014 00:00:00 +0000 <![CDATA[Lichtenegger, F.S. et al. Next-generation dendritic cell vaccination as postremission therapy for AML patients with a non-favorable risk profile. Oncol. Res. Treat. 37, 310 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42867&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42867&la=de Mon, 01 Dec 2014 00:00:00 +0000 <![CDATA[Malkomes, P.* et al. Characterization of colon cancer stem cells at the single cell level for target identification in diagnosis and therapy. Oncol. Res. Treat. 37, 120 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=31060&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=31060&la=de Mon, 14 Apr 2014 00:00:00 +0000 <![CDATA[Neumann, M.* et al. T-ALL is characterized by heterogeneous pattern of gene mutations and their variant allele frequencies. Oncol. Res. Treat. 37, 180 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42864&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42864&la=de Mon, 01 Dec 2014 00:00:00 +0000 <![CDATA[Peter, N. et al. Interaction of anti-CD20 antibodies and inhibitors of the B-cell receptor pathway in diffuse large B-cell lymphoma. Oncol. Res. Treat. 37, 72 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42860&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42860&la=de Mon, 01 Dec 2014 00:00:00 +0000 <![CDATA[Yabal, M.* et al. Aberrant TNF signalling in dendritic cells in the absence of XIAP contributes to X-linked lymphoproliferative disease (XLP-2) by exaggerated necroptosis. Oncol. Res. Treat. 37, 246 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42863&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42863&la=de Mon, 01 Dec 2014 00:00:00 +0000 <![CDATA[Zhao, Y.* et al. CXCR4 over-expression is associated with Cisplatin resistance in esophageal carcinoma. Oncol. Res. Treat. 37, 99 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=31061&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=31061&la=de Mon, 14 Apr 2014 00:00:00 +0000 <![CDATA[Zoellner, A.-K. et al. Efficacy of PI3K-inhibitors in Mantle Cell Lymphoma (MCL). Oncol. Res. Treat. 37, 72 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42866&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=42866&la=de Mon, 01 Dec 2014 00:00:00 +0000